A congressional committee has approved a GOP-led psychedelics bill focused on military veterans’ access. The proposal, advanced by Rep. Derrick Van Orden (R-WI), aims to address the potential therapeutic benefits of psychedelics for veterans suffering from various mental health conditions.
Bill Overview
The bill requires the U.S. Department of Veterans Affairs (VA) to notify Congress if any psychedelics are added to its formulary of covered prescription drugs. VA must report to Congress within 180 days of the federal approval of psychedelic medicines by the Food and Drug Administration (FDA).
Current Landscape
While there are currently no federally approved psychedelic drugs for prescription, recent developments indicate potential changes. FDA has agreed to review a new drug application for MDMA-assisted therapy and designated substances like psilocybin and LSD-like compounds as “breakthrough therapies.”
Legislative Actions
Rep. Van Orden, the bill’s sponsor, is also a co-sponsor of bipartisan legislation to fund clinical trials on psychedelics for active duty military members. Additionally, appropriations leaders have included $10 million in a spending package for psychedelics studies.
Medical Cannabis Measure
The House Veterans’ Affairs Health Subcommittee also approved a medical cannabis measure, the Veterans Cannabis Analysis, Research, and Effectiveness (CARE) Act. This legislation, sponsored by Rep. Mariannette Miller-Meeks (R-IA), focuses on researching the efficacy and safety of cannabis for veterans with chronic pain, PTSD, and other conditions.
Support and Obstacles
While VA voiced support for the medical cannabis bill with certain amendments, progress on this front has been slower. Senate Republicans blocked a procedural motion to advance a similar bill last year.
The approval of the GOP-led psychedelics bill by the congressional committee represents a significant step toward expanding therapeutic options for military veterans. Despite obstacles, bipartisan efforts continue to explore the potential benefits of psychedelics and cannabis in addressing veterans’ mental health needs.